KELLY RICE: Open Payments
NPI 1104864222 · DETROIT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,375 in 54 payments from 17 companies in 2025. Trend: 2023 $3,715 · 2024 $1,214 · 2025 $1,375
Food & beverage: $1,375
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 3 | $240 |
| SCPHARMACEUTICALS INC. | 8 | $156 |
| Novo Nordisk Inc | 6 | $149 |
| Novartis Pharmaceuticals Corporation | 6 | $131 |
| Alnylam Pharmaceuticals Inc. | 3 | $103 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 5 | $95 |
| AstraZeneca Pharmaceuticals LP | 4 | $82 |
| Merck Sharp & Dohme LLC | 4 | $81 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $72 |
| PFIZER INC. | 3 | $61 |
Products named: FUROSCIX, Wegovy, LEQVIO, General - Therapies, EMPOWER Leadless Pacemaker System_CRM, AMVUTTRA, LifeVest, VERQUVO.
Industry payments across MI — which companies pay providers there.
